Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer | Anticancer Research
Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer - Annals of Oncology
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives
MET Inhibitors for the Treatment of Gastric Cancer: What's Their | JEP
Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer | Anticancer Research
MET amplified gastric cancer cells undergo growth arrest when exposed... | Download Scientific Diagram
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification | BMC Cancer | Full Text
MET Amplification and Efficacy of Nivolumab in Patients With NSCLC - JTO Clinical and Research Reports
A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification - European Journal of Cancer
Frontiers | HGF/c-Met Axis: The Advanced Development in Digestive System Cancer | Cell and Developmental Biology
Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer | Cell Death & Disease
KEGG PATHWAY: Gastric cancer - Reference pathway
cMET as a potential therapeutic target in gastric cancer (Review)
Signalling pathway and targeted therapy in gastric cancer. Percentages... | Download Scientific Diagram
MET amplified gastric cells undergo apoptosis when exposed to... | Download Scientific Diagram
Emergence of Concurrent Multiple EGFR Mutations and MET Amplification in a Patient With EGFR-Amplified Advanced Gastric Cancer Treated With Cetuximab | JCO Precision Oncology
![TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/11146/1/fig-4-1x.jpg "TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer [PeerJ]")
TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer [PeerJ]
Prevalence of MET amplification and increased MET gene copy number... | Download Table
Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer | Cell Death & Disease
Table 1 from Amplification MET ( PF-02341066 ) in Gastric Cancer Positive for Antitumor Action of the MET Tyrosine Kinase Inhibitor Crizotinib | Semantic Scholar
Effect of foretinib on gastric cancer (GC) cells positive for c-MET... | Download Scientific Diagram
MET-dependent solid tumours — molecular diagnosis and targeted therapy | Nature Reviews Clinical Oncology
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752 | PNAS
PLOS ONE: Prognostic Significance of MET Amplification and Expression in Gastric Cancer: A Systematic Review with Meta-Analysis
Introduction
The multiple paths towards MET receptor addiction in cancer | Oncogene
